Cardiovascular prevention at the crossroads
- 17 April 2026
- journal article
- Published by Oxford University Press (OUP) in European Journal of Preventive Cardiology
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- Combination of cardioprotective glucose-lowering drugs and statins on cardiovascular mortality in diabetes: a nationwide cohort studyEuropean Journal of Preventive Cardiology, 2026
- 10. Cardiovascular Disease and Risk Management: Standards of Care in Diabetes—2025Diabetes Care, 2024
- Effects of semaglutide with and without concomitant SGLT2 inhibitor use in participants with type 2 diabetes and chronic kidney disease in the FLOW trialNature Medicine, 2024
- GLP-1 receptor agonists and cardiorenal outcomes in type 2 diabetes: an updated meta-analysis of eight CVOTsCardiovascular Diabetology, 2021
- Association of SGLT2 Inhibitors With Cardiovascular and Kidney Outcomes in Patients With Type 2 DiabetesJAMA Cardiology, 2021
- Why is translating research into policy so hard? How theory can help public health researchers achieve impact?Public Health, 2020